Source comparison
Best Peptides for Post-Surgery Recovery: Research Compound Comparison
This table compares the most researched peptides for post-surgical recovery based on mechanism of action, targeted healing phase, typical dosing protocols, and evidence quality. BPC-157 VEGF upregulation, angiogenesis, collagen synthesis Proliferation (days 4–
This comparison does not assign a generated winner or score.
- This table compares the most researched peptides for post-surgical recovery based on mechanism of action, targeted healing phase, typical dosing protocols, and evidence quality.
- BPC-157
- VEGF upregulation, angiogenesis, collagen synthesis
- Proliferation (days 4–21)
- 250–500 mcg SC daily
- Multiple animal studies, limited human data
- Best-characterized wound healing peptide with consistent results across tissue types
- TB-500 (Thymosin Beta-4)
- Actin polymerization, cell migration, anti-fibrotic effects
- Proliferation and remodeling (days 4–60)
- 2–5 mg SC twice weekly
- Extensive preclinical data, Phase 2 human trials for specific indications
- Particularly valuable for tendon, ligament, and muscle repair procedures
- Thymosin Alpha-1
- T-cell maturation, immune modulation, infection prevention
- Inflammation (days 0–7)
- 1.6 mg SC twice weekly
- Multiple RCTs in surgical populations
- Only peptide with Level 1 evidence in post-operative human populations
- GHK-CU (Copper Peptide)
- Collagen/elastin synthesis, TIMP production, NF-kB modulation
- Remodeling (days 21–90)
- 2–5 mg SC 3x weekly or 1–3% topical daily
- Moderate preclinical evidence, weak clinical evidence
- Best option for cosmetic outcomes and scar quality in skin procedures
- Ipamorelin
- GH secretagogue, increases endogenous growth hormone
- All phases (days 0–42)
- 200–300 mcg SC 2–3x daily
- Strong preclinical evidence, no surgical-specific human trials
- Addresses systemic protein synthesis rather than local wound factors
- Cerebrolysin
- Neurotrophic factor delivery (BDNF, NGF), neuroprotection
- 10–30 mL IV daily for 10–20 days
- Moderate evidence in stroke models, limited surgical trauma data
- Niche application: neurosurgical and peripheral nerve injury recovery